​DIRECT MONITORING of a Patient’s Heart 

HemoCath is an intelligent heart failure (HF) monitoring platform that has significant potential to reduce hospital stay for HF patients.

HemoCath provides the most important measures of cardiac function and fluid status. It allows more frequent/accurate adjustments of medication dosing for heart failure patients – so patients more rapidly reach their optimal fluid level – leading to better patient outcomes and sooner hospital discharge. HemoCath (4F) is easily inserted into a vein on the upper arm and connected to a secure cloud.

​NOTIFYING Clinicians to Take Action Before a Patient's Next Major Heart Failure

HemoCath platform closely monitors a patient's heart and notifies healthcare professionals when a patient's condition is worsening.

Heart failure is a global pandemic affecting at least 26 million people worldwide  —  ​5.7 million people in the US  —  and projections in the near future are worrisome. HF health expenditures are considerable and will increase dramatically with an ageing population.